Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Gudang Garam Tbk. (GGRM) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Gudang Garam Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Gudang Garam Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Gudang Garam Tbk. diperdagangkan di Rp20.300 (kapitalisasi pasar 37,66 T, volume 24 jam 1,2 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 177,6 rb). Perbedaan utamanya: Gudang Garam Tbk. jauh lebih besar — sekitar 228,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Gudang Garam Tbk. lebih aktif diperdagangkan (1,2 jt vs 177,6 rb). Mana yang lebih baik tergantung tujuan investasimu.

GGRMOBAT
Kapitalisasi Pasar
37,66 T164,65 M
Volume
1,2 jt177,6 rb
Lot
12,04 rb1,78 rb
Perputaran
24,25 M42 jt
Harga Rata-rata
20.144,02236,47
Nilai Transaksi
24,25 M42 jt
Harga Ekuilibrium Indikatif
19.575242
Volume Ekuilibrium Indikatif
14,7 rb500

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

GGRM
Lihat detail
OBAT
Lihat detail

Tentang Gudang Garam Tbk.

PT Gudang Garam Tbk (the Company), previously named as PT Perusahaan Rokok Tjap Gudang Garam Kediri was established by Deed of Mr. Suroso S.H., acting notary public in Kediri, dated 30 June 1971 No. 10 amended by deed of the same notary dated 13 October 1971 No. 13. The Company is a continuation of a Proprietorship which was established in 1958. In 1969, the Company changed its legal status to a Partnership and in 1971 it was further changed its legal entity as a Limited Liability Company. Commercial operation was commenced in 1958.

Selengkapnya di halaman GGRM

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT